 |
|
Consumers will
benefit from a range of products containing
high-amylose wheat |
|
Australia
November 2, 2006
A$12.5 million partnership targets
healthy grain
CSIRO, through the
Food Futures Flagship,
Limagrain Céréales Ingrédients and the
Grains Research and Development
Corporation (GRDC) have announced a partnership to
accelerate the development of new super-healthy wheat varieties.
The High Amylose Wheat Joint
Venture will conduct research and development into high amylose
wheat from core technology developed by
CSIRO Plant Industry and
Biogemma (Limagrain’s
biotech subsidiary).
“The development of high amylose wheat varieties will also be
good for farmers,” says Terry Enright, Chairman of the Grains
Research and Development Corporation.
“Earlier this year CSIRO reported the development of the first
of the new wheats, with amylose levels increased from about 25
to 70 per cent.”“New value-added varieties will provide the
Australian grains industry with the opportunity to market
differentiated high-value niche grains in both domestic and
foreign markets.”
The focus of the joint venture will be to deliver new wheat
varieties with high levels of amylose (or resistant starch) and
develop commercial relationships to take products through to
market. The partnership holds exceptional promise for the
development of new healthy wheats and wheat-based foods.
|
Earlier
this year CSIRO reported the development of the first of
the new wheats, with amylose levels increased from about
25 to 70 per cent. |
“High-amylose wheat can be
incorporated as wholegrain into breads, cereals and other foods
and will have a high level of resistant starch, a low glycaemic
index, and deliver benefits for bowel health. These properties
give the grain the potential to be useful in tackling the
problems of type II diabetes, the prevention of colorectal
cancer and obesity,” says Dr Bruce Lee, Director of the Food
Futures Flagship.
"Good progress towards healthier wheat has already been made
through the partnership between Biogemma and CSIRO, which has
been running since 1996," says Alain Perrin, Managing Director
of Limagrain Céréales Ingrédients.
“The new joint venture will further accelerate development of
this exciting area of functional foods.”
BACKGROUND
The High Amylose Wheat Joint
Venture will conduct research and development into high amylose
wheat from core technology developed by CSIRO Plant Industry and
Biogemma (Limagrain’s Biotech subsidiary).
The focus of the joint venture will be to deliver new wheat
varieties with high levels of amylose (or resistant starch) and
develop commercial relationships to take products through to
market.
High-amylose wheat can be incorporated as wholegrain into
breads, cereals and other foods and will have a high level of
resistant starch, a low glycaemic index, and deliver benefits
for bowel health
RELATED RELEASE:
-
GRDC invests in wheat technology for healthy
future
- Australia's Grains Research and
Development Corporation invests in wheats for healthy future |
